Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthay

Showing results (1141-1150 of 1,339) with videos related to

Pageof 134
Sort By:
International Journal of Radiation Oncology, Biology, Physics|December 16, 2022
Modulation of Radiation Biomarkers in a Randomized Phase II Study of <sup>131</sup>I-MIBG With or Without Radiation Sensitizers for Relapsed or Refractory NeuroblastomaKevin Campbell, Susan Groshen, Angela C Evans, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 17, 2023
Plasma metabolic profiling implicates dysregulated lipid metabolism and glycolytic shift in hyperinflammatory ARDSNarges Alipanah-Lechner, Lucile Neyton, Eran Mick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group studyJ M Maris, M J Weiss, C Guo, et al.
Pediatric Blood & Cancer|July 2, 2013
Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: a report from the New Approaches to Neuroblastoma Therapy (NANT) consortiumBarry J Maurer, Min H Kang, Judith G Villablanca, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 7, 2012
The 4G/4G genotype of the PAI-1 (serpine-1) 4G/5G polymorphism is associated with decreased lung allograft utilizationA Sapru, J G Zaroff, L Pawlikowska, et al.
Cancer|September 14, 2022
Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning MeetingJulie R Park, Judith G Villablanca, Barbara Hero, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|August 5, 2016
A Simple and Robust Bedside Model for Mortality Risk in Pediatric Patients With Acute Respiratory Distress SyndromeAaron C Spicer, Carolyn S Calfee, Matthew S Zinter, et al.
Physiological Reports|December 12, 2025
Biological sex modulates lung injury severity in adolescent mice exposed to short-term aerosolized vitamin E acetateMichelle J Lim, Xiaohan Li, Jihau Yu, et al.
Journal of Pediatric Hematology/Oncology|December 10, 2019
Germline MUTYH Mutation in a Pediatric Cancer Survivor Developing a Secondary MalignancyVincent Lavergne, Amit Sabnis, Asmin Tupule, et al.
JAMA|July 15, 2005
Effect of prone positioning on clinical outcomes in children with acute lung injury: a randomized controlled trialMartha A Q Curley, Patricia L Hibberd, Lori D Fineman, et al.
Pageof 134

Showing results (1141-1150 of 1,339) with videos related to

Sort By:
Pageof 134
International Journal of Radiation Oncology, Biology, Physics|December 16, 2022
Modulation of Radiation Biomarkers in a Randomized Phase II Study of <sup>131</sup>I-MIBG With or Without Radiation Sensitizers for Relapsed or Refractory NeuroblastomaKevin Campbell, Susan Groshen, Angela C Evans, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 17, 2023
Plasma metabolic profiling implicates dysregulated lipid metabolism and glycolytic shift in hyperinflammatory ARDSNarges Alipanah-Lechner, Lucile Neyton, Eran Mick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group studyJ M Maris, M J Weiss, C Guo, et al.
Pediatric Blood & Cancer|July 2, 2013
Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: a report from the New Approaches to Neuroblastoma Therapy (NANT) consortiumBarry J Maurer, Min H Kang, Judith G Villablanca, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 7, 2012
The 4G/4G genotype of the PAI-1 (serpine-1) 4G/5G polymorphism is associated with decreased lung allograft utilizationA Sapru, J G Zaroff, L Pawlikowska, et al.
Cancer|September 14, 2022
Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning MeetingJulie R Park, Judith G Villablanca, Barbara Hero, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|August 5, 2016
A Simple and Robust Bedside Model for Mortality Risk in Pediatric Patients With Acute Respiratory Distress SyndromeAaron C Spicer, Carolyn S Calfee, Matthew S Zinter, et al.
Physiological Reports|December 12, 2025
Biological sex modulates lung injury severity in adolescent mice exposed to short-term aerosolized vitamin E acetateMichelle J Lim, Xiaohan Li, Jihau Yu, et al.
Journal of Pediatric Hematology/Oncology|December 10, 2019
Germline MUTYH Mutation in a Pediatric Cancer Survivor Developing a Secondary MalignancyVincent Lavergne, Amit Sabnis, Asmin Tupule, et al.
JAMA|July 15, 2005
Effect of prone positioning on clinical outcomes in children with acute lung injury: a randomized controlled trialMartha A Q Curley, Patricia L Hibberd, Lori D Fineman, et al.
Pageof 134